Skip to main content

Table 2 Prevalence of rifampicin resistance among TB patients in the survey, overall and by previous anti-TB treatment history

From: Experience on the first national anti-TB drug resistance survey (DRS) in Timor-Leste

  Total TB cases RR-TB % (95% CI)
New patients 844 5 0.6 (0.2–1.3)
Previously treated patients 73 2 2.7 (0.5–8.2)
All patients 917 7 0.8 (0.3–1.5)
  1. RR-TB rifampicin resistant tuberculosis, 95% CI 95% confidence intervals